Dimeric inhibin A as a marker for Down's syndrome in early pregnancy

New England Journal of Medicine

Volumn 334, Issue 19, 1996, Pages 1231-1236

  Aitken, David A ^a   Wallace, Euan M ^b   Crossley, Jennifer A ^a   Swanston, Ian A ^b   Van Pareren, Yvonne ^a   Van Maarle, Merel ^a   Groome, Nigel P ^c   Macri, James N ^d   Connor, J Michael ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d NTD Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 18;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INHIBINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REFERENCE VALUES; TRISOMY;

EID: 0029869141     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605093341904     Document Type: Article

References (44)

1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94
2. Bogart MH, Pandian MR, Jones OW Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
3. Macri JN, Kasturi RV, Krantz DA, et al. Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990;163:1248-53.
4. Spencer K. Evaluation of an assay of the free β-subunit of choriogonadotropin and its potential value in screening for Down's syndrome Clin Chem 1991;37:809-14.
5. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome Br J Obstet Gynaecol 1988;95 330-3
6. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988,95.334-41.
7. Cuckle HS, Wald NJ, Thompson S. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987.94:387-402.
8. Zeitune M, Aitken DA, Crossley JA, Yates JRW, Cooke A, Ferguson-Smith MA. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age. a retrospective study of 142 pregnancies. Prenat Diagn 1991,11:847-57.
9. Reynolds TM, Penney MD The mathematical basis of multivariate risk screening, with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1990;27:452-8.
10. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy BMJ 1988,287 883-7. [Erratum, BMJ 1988,297.1029]
11. Crossley JA, Aitken DA, Connor JM. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-feroprotein, and age. Prenat Diagn 1991;11:83-101
12. Spencer K, Coombes EJ, Mallard AS, Ward AM. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992,29:506-18
13. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93
14. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome, results of a demonstration project BMJ 1992,305:391-4
15. Goodburn SF, Yates JRW, Raggatt PR, et al. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Prenat Diagn 1994;14 391-402.
16. Crossley JA, Aitken DA, Berry E, Connor JM. Impact of a regional screening programme using maternal serum α fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland. J Med Screening 1994,1:180-3
17. Spencer K, Carpenter P Prospective study of prenatal screening for Down's syndrome with free β human chorionic gonadotrophin. BMJ 1993,307.764-9.
18. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN Jr, Panizza DS. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn 1992,12 925-30.
19. Spencer K, Mallard AS, Coombes EJ, Macri JN Prenatal screening for trisomy 18 with free β human chorionic gonadotrophin as a marker. BMJ 1993,307:1455-8.
20. Brock DJH, Barron L, Holloway S, Liston WA, Hillier SG, Seppalla M First-trimester maternal serum biochemical indicators in Down syndrome Prenat Diagn 1990,10.245-51
21. Aitken DA, McCaw G, Crossley JA, et al First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat Diagn 1993,13:681-9.
22. Macri JN, Spencer K, Aitken DA, et al First-trimester free beta (hCG) screening for Down syndrome. Prenat Diagn 1993;13:557-62.
23. Van Lith JMM, Pratt JJ, Beekhuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992,12.801-6.
24. Spencer K, Wood PJ, Anthony FW. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome. Ann Clin Biochem 1993,30 219-20.
25. Cuckle HS, Holding S, Jones R. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Prenat Diagn 1994;14:387-90.
26. Wallace EM, Harkness LM, Burns S, Liston WA Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clin Endocrinol 1994;41:483-6.
27. Van Lith JMM, Mantingh A, Pratt JJ. First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Obstet Gynecol 1994;83:661-4.
28. Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome. Prenat Diagn 1995;15:359-62.
29. Cuckle HS. Holding S, Jones R, Wallace EM, Groome NP, Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies. Prenat Diagn 1995,15 385-6.
30. Spencer K, Aitken DA, Crossley JA, et al. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem 1994:31.447-54.
31. Groome N, O'Brien M Immunoassays for inhibin and its subunits: further applications of the synthetic peptide approach J Immunol Methods 1993;165:167-76.
32. Groome NP, Illingworth PJ, O'Brien M, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994;40:717-23.
33. Macri JN, Spencer K, Anderson RW, Cook EJ. Free beta-chorionic gonadotropin: a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down's syndrome. Ann Clin Biochem 1993;30:94-8
34. Miyamoto K, Hasegawa Y, Fukuda M, et al. Isolation of porcine follicular fluid inhibin of 32K daltons. Biochem Biophys Res Commun 1985;129:396-403.
35. Robertson DM, Sullivan J, Watson M, Cahir N. Inhibin forms in human plasma. J Endocrinol 1995;144:261-9.
36. Tovanabutra S, Illingworth PJ, Ledger WL, Glasier AF, Baird DT The relationship between peripheral immunoreactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy Clin Endocrinol 1993;38:101-7
37. McLachlan RI, Healy DL, Lutjen PJ, Findlay JK, De Kretser M, Burger HG. The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clin Endocrinol 1987;27:663-8.
38. Qu J, Vankrieken L, Burulet C, Thomas K. Circulating bioactive inhibin levels during pregnancy. J Clin Endocrinol Metab 1991;72:862-6.
39. Schneyer AL, Mason AJ, Burton LE, Zeigner JR, Crowley WF Jr Immunoreactive inhibin α-subunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab 1990;70 1208-12.
40. Macintosh MCM, Brambati B, Chard T, Grudzinskas JG. First-trimester maternal serum Schwangerschafts protein (SP) in pregnancies associated with chromosomal anomalies Prenat Diagn 1993;13:563-8.
41. Graham GW, Crossley JA, Aitken DA, Connor JM Variation in the levels of pregnancy-specific β-1 glycoprotein in maternal serum from chromosomally abnormal pregnancies. Prenal Diagn 1992;12:505-12.
42. Macri IN, Spencer K, Garver K, et al. Maternal serum free beta hCG screening, results of studies including 480 cases of Down syndrome. Prenat Diagn 1994;14:97-103.
43. Canick JA, Lambert-Messerlian GM, Palomaki GE, et al. Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy. Am J Hum Genet 1994,55.Suppl A9 abstract.
44. Crossley JA, Aitken DA, Connor JM. Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. Prenat Diagn 1993;13:271-80.